Invest in

Fighting Fat

11.7%
2.5%
1.4%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
11.7%
2.5%
1.4%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
55.6% Diabetes Care 10.4%
20.3% Novo-Nordisk A/S ADR NVO 4.4%
17.0% Sanofi ADR (Sponsored) SNY 16.4%
11.0% Merck & Co. Inc MRK 3.7%
3.3% Astrazeneca Plc ADR AZN 11.4%
2.3% Alkermes plc ALKS 28.3%
1.7% Greatbatch Inc GB 39.2%
35.9% Weight Management 19.8%
15.1% NutriSystem Inc NTRI 21.8%
8.1% Medifast Inc MED 7.5%
4.5% Weight Watchers International Inc. WTW 117.9%
2.1% Nu Skin Enterprises Inc. (A) NUS 23.0%
2.1% GNC Holdings Inc GNC 44.0%
2.0% USANA Health Sciences Inc. USNA 4.9%
1.9% Vitamin Shoppe VSI 29.9%
8.4% Weight Loss Drugs 64.5%
7.4% Arena Pharmaceuticals Inc. ARNA 60.5%
1.1% Orexigen Therapeutics Inc. OREX 91.6%

Quotes delayed 15 mins. Currently May 25, 2016 12:49:13 PM. Fields are marked with -- when data is unavailable.